Covered recipient · General Payments record
ANA L DELGADO
Allopathic & Osteopathic Physicians Psychiatry & Neurology Neurology
General Payments · PY2019–2025
$10,952.89
- Reported across 247 records
- CMS publication 2026-06-30
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2025 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $426.91 | 17 |
By paying entity
PY2025 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $272.86 | 10 |
| Biogen, Inc. | $39.57 | 2 |
| UCB, Inc. | $31.87 | 1 |
| Amneal Pharmaceuticals LLC | $27.94 | 1 |
| ACADIA Pharmaceuticals Inc | $20.68 | 1 |
| ARGENX US, INC. | $19.14 | 1 |
| Neurocrine BioSciences, Inc. | $14.85 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2025 (17)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $29.98 | 01/28/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1201747152 | CMS |
| ABBVIE INC. | $28.19 | 01/30/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1201747154 | CMS |
| ABBVIE INC. | $32.21 | 02/05/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1201747156 | CMS |
| ABBVIE INC. | $30.90 | 02/20/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1201747158 | CMS |
| ABBVIE INC. | $31.27 | 03/27/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1201747160 | CMS |
| ABBVIE INC. | $23.60 | 04/09/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1201747162 | CMS |
| ABBVIE INC. | $29.78 | 05/14/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1201747164 | CMS |
| ABBVIE INC. | $13.47 | 06/18/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1201747166 | CMS |
| ABBVIE INC. | $34.66 | 06/19/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1201747168 | CMS |
| ABBVIE INC. | $18.80 | 06/25/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1201747170 | CMS |
| ACADIA Pharmaceuticals Inc | $20.68 | 01/13/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1247771022 | CMS |
| Amneal Pharmaceuticals LLC | $27.94 | 04/17/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1220531583 | CMS |
| ARGENX US, INC. | $19.14 | 05/15/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1240438324 | CMS |
| Biogen, Inc. | $18.04 | 02/26/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1208382729 | CMS |
| Biogen, Inc. | $21.53 | 05/06/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1208482862 | CMS |
| Neurocrine BioSciences, Inc. | $14.85 | 06/25/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1243043347 | CMS |
| UCB, Inc. | $31.87 | 04/16/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1224470216 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-06-30
- Program years on this page
- 2019, 2020, 2021, 2022, 2023, 2024, 2025
- Source files
- Dataset page · Bulk file · PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024 , PY2025
- Generated from
- OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.